This article dives into effective strategies to help you acquire surgery patients for your practice, so you can grow and maintain positive cash flow. Acquiring new patients is essential to generating revenue in your practice, but the challenge of finding potential new patients can be daunting. Read on to explore practical strategies for attracting new […]
04
Jan
Jan
This article offers an overview of how virtual consultations work for bariatric surgery. While COVID-19 may have triggered a surge in telehealth visits, there are no signs that the trend is slowing. Knowing how to lead effective virtual consultations can increase surgery follow-through rates and improve patient outcomes. If you’re still feeling uncomfortable using technology […]
- 1
- 2
The epitome of an entrepreneur, Mark has seen the peaks and valleys of starting, operating, and assuming the risks of a new venture. He’s come up against payroll, had a few bad hires, and even swept the floors early on. Collectively, Mark’s companies have done over $360 million in sales and raised more than $38 million in venture capital, and he has successfully bought and/or sold eight companies.
James believes technology, when creatively applied, can improve our life experiences. Intrigued by the amazing potential for internet and mobile technology to engage us all, James created a business model to reshape personal health management.
Mike Splinter, an electrical engineer and innovator, has played a major role in driving advances in the high tech industry, with more than four decades of executive leadership experience including 12 years with Applied Materials, Inc. where he was served as chairman and CEO, and over 20 years with Intel, where he was executive vice president of sales and marketing, and executive vice president of the Technology and Manufacturing Group.
Mr. Baldwin was most recently Chairman and CEO of Baxa Corporation, a leader in devices, systems, and software for the handling, packaging, and tracking of fluid medications in a critical care setting. Under his leadership from 1997 until its sale to Baxter Corporation in 2011, the company sales grew from $25 million to over $170 million. As CEO, he led the eight-member board of directors and led a minority recap resulting in Goldman Sach’s private equity group owning 27% of the company. He was also an early investor and lead director in Pharmacy OneSource, an innovative software-as-a-service business that had a successful exit in 2010.